138 related articles for article (PubMed ID: 30379067)
1. Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
Bian L; Gao M; Zhang D; Ji A; Su C; Duan X; Luo Q; Huang D; Feng Y; Ni Y; Yin Z; Jin Q; Zhang J
Anal Chem; 2018 Nov; 90(22):13249-13256. PubMed ID: 30379067
[TBL] [Abstract][Full Text] [Related]
2. Rhein-based necrosis-avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy.
Wu T; Zhang J; Jin Q; Gao M; Zhang D; Zhang L; Feng Y; Ni Y; Yin Z
Magn Reson Med; 2019 Dec; 82(6):2212-2224. PubMed ID: 31418484
[TBL] [Abstract][Full Text] [Related]
3. Inflammation targeted Gd(3+)-based MRI contrast agents imaging tumor and rheumatoid arthritis models.
Leung AH; Jin J; Wang S; Lei H; Wong WT
Bioconjug Chem; 2014 Jun; 25(6):1112-23. PubMed ID: 24857314
[TBL] [Abstract][Full Text] [Related]
4. Design and Evaluation of Rhein-Based MRI Contrast Agents for Visualization of Tumor Necrosis Induced by Combretastatin A-4 Disodium Phosphate.
Zhang L; Zhang D; Gao M; Jin Q; Jiang C; Wu T; Feng Y; Ni Y; Yin Z; Zhang J
Mol Imaging Biol; 2021 Apr; 23(2):220-229. PubMed ID: 33048270
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of Diindole-Based MRI Contrast Agent for In Vivo Visualization of Necrosis.
Zhang L; Liu L; Zhang D; Jin Q; Gao M; Wu T; Feng Y; Ni Y; Yin Z; Zhang J
Mol Imaging Biol; 2020 Jun; 22(3):593-601. PubMed ID: 31332630
[TBL] [Abstract][Full Text] [Related]
6. Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.
Boros E; Polasek M; Zhang Z; Caravan P
J Am Chem Soc; 2012 Dec; 134(48):19858-68. PubMed ID: 23157602
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis.
Zhang A; Wu T; Bian L; Li P; Liu Q; Zhang D; Jin Q; Zhang J; Huang G; Song S
Mol Imaging Biol; 2020 Jun; 22(3):515-525. PubMed ID: 31250330
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-Labeled Aminoglycoside and Its Potential Application as a Bacteria-Targeting Magnetic Resonance Imaging Contrast Agent.
Zhang L; Liu Y; Zhang Q; Li T; Yang M; Yao Q; Xie X; Hu HY
Anal Chem; 2018 Feb; 90(3):1934-1940. PubMed ID: 29293308
[TBL] [Abstract][Full Text] [Related]
9. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
[TBL] [Abstract][Full Text] [Related]
10. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
[TBL] [Abstract][Full Text] [Related]
11. The interplay of T1- and T2-relaxation on T1-weighted MRI of hMSCs induced by Gd-DOTA-peptides.
Cao L; Li B; Yi P; Zhang H; Dai J; Tan B; Deng Z
Biomaterials; 2014 Apr; 35(13):4168-74. PubMed ID: 24560458
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
[TBL] [Abstract][Full Text] [Related]
13. SPECT Imaging of Treatment-Related Tumor Necrosis Using Technetium-99m-Labeled Rhein.
Liang J; Luo Q; Zhang D; Jin Q; Liu L; Liu W; Gao M; Zhang J; Yin Z
Mol Imaging Biol; 2019 Aug; 21(4):660-668. PubMed ID: 30338432
[TBL] [Abstract][Full Text] [Related]
14. Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent.
Park JA; Lee JJ; Jung JC; Yu DY; Oh C; Ha S; Kim TJ; Chang Y
Chembiochem; 2008 Nov; 9(17):2811-3. PubMed ID: 18956393
[No Abstract] [Full Text] [Related]
15. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium.
Luo Q; Jin Q; Su C; Zhang D; Jiang C; Fish AF; Feng Y; Ni Y; Zhang J; Yin Z
Anal Chem; 2017 Jan; 89(2):1260-1266. PubMed ID: 27981843
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
[TBL] [Abstract][Full Text] [Related]
19. A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
Kalber TL; Kamaly N; So PW; Pugh JA; Bunch J; McLeod CW; Jorgensen MR; Miller AD; Bell JD
Mol Imaging Biol; 2011 Aug; 13(4):653-62. PubMed ID: 20809208
[TBL] [Abstract][Full Text] [Related]
20. Synthetic approaches to heterocyclic ligands for Gd-based MRI contrast agents.
Pérez-Mayoral E; Soler-Padrós J; Negri V; Cerdán S; Ballesteros P
Molecules; 2007 Aug; 12(8):1771-95. PubMed ID: 17960087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
